-
Product Insights
Buffalo Trail Wind Farm – Northland
Buffalo Trail Wind Farm - Northland is an Onshore Wind project located in Alberta, Canada. The project is owned and being developed by Northland Power Inc. The project is at the permitting stage. Empower your strategies with our Buffalo Trail Wind Farm - Northland report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and...
-
Product Insights
Northland Power N4 Offshore Wind Project
Spiorad na Mara is an offshore wind project located in North Sea, United Kingdom. The project is owned and being developed by Northland Power Inc. The project is at the permitting stage. Empower your strategies with our Spiorad na Mara report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of...
-
Company Insights
Innovation and Patenting activity of Northland Power Inc Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Northland Power Inc Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Product Insights
New Zealand Gov – SH25A Kopu To Hikuai Highway Upgrade – Northland Region
Equip yourself with the essential tools needed to make informed and profitable decisions with our New Zealand Gov – SH25A Kopu To Hikuai Highway Upgrade – Northland Region report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to buy Acquire a...
-
Product Insights
Mitsui/ Northland Power/ Yushan Energy – Hai Long Offshore Wind Power Plant 1044 MW – Taiwan
Equip yourself with the essential tools needed to make informed and profitable decisions with our Mitsui/ Northland Power/ Yushan Energy – Hai Long Offshore Wind Power Plant 1044 MW – Taiwan report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Atamparib in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Atamparib in Solid Tumor report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Atamparib in Solid Tumor Drug Details: Atamparib (RBN-2397) is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Relatlimab in Diffuse Large B-Cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Relatlimab in Diffuse Large B-Cell Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Relatlimab in Diffuse Large B-Cell Lymphoma Drug Details: Relatlimab (BMS-986016)...
-
Product Insights
Hemorrhagic Fever – Drugs In Development, 2023
Global Markets Direct’s, ‘Hemorrhagic Fever - Drugs In Development, 2023’, provides an overview of the Hemorrhagic Fever pipeline landscape. The report provides comprehensive information on the therapeutics under development for Hemorrhagic Fever, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Ischemia Reperfusion Injury – Drugs In Development, 2023
Global Markets Direct’s, ‘Ischemia Reperfusion Injury - Drugs In Development, 2023’, provides an overview of the Ischemia Reperfusion Injury pipeline landscape. The report provides comprehensive information on the therapeutics under development for Ischemia Reperfusion Injury, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Post Menopausal Osteoporosis – Drugs In Development, 2023
Global Markets Direct’s, ‘Post Menopausal Osteoporosis - Drugs In Development, 2023’, provides an overview of the Post Menopausal Osteoporosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Post Menopausal Osteoporosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...